|
|
|
|
Science Sparks @ ACTREC
|
 27th November 2023 |
Vol. No. 12; Issue No. 606 |
|
|
Publications
|
|
1. Pahwa V, Pimple S, Bhattacharjee A, Kuberkar D, Mishra G, Chaturvedi P (2023). Behavioural interventions for tobacco cessation in India: A systematic review and meta-analysis. Journal of Family Medicine and Primary Care. 12(11): 2542-2551.
2. Noronha V, Dhanawat A, Patil VM, Menon N, Singh AK, Chaturvedi P, Pai P, Chaukar D, Laskar SG, Prabhash K (2024). Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice. Oral Oncology. 148: 106633.
3. Chatterjee S, Ganguly A, Bhattacharyya D(2023). Reprogramming nucleolar size by genetic perturbation of the extranuclear Rab GTPases Ypt6 and Ypt32. FEBS Letters.
4. Jain H, Shetty D (2023). Role of cytogenetics and fluorescence In situ hybridization in the laboratory workup of acute myeloid leukemias. Indian Journal of Medical and Paediatric Oncology. 44(06): 543-553.
5. Tembhare P (2023). Monitoring measurable/minimal residual disease in acute myeloid leukemia: Multiparametric flow cytometry-based approach. Indian Journal of Medical and Paediatric Oncology. 44(06): 554-565.
Thesis
Siddhartha Anup Barua. 2023. A structure-based approach to elucidate protein-protein interactions of BRCT repeats. (LIFE09201604013) (Guide: Dr. Ashok Varma)
|
|
|
|
|
Interesting Reads
|
|
Cao K, Xia Y, Yao J, Han X, Lambert L, Zhang T, Tang W, Jin G, Jiang H, Fang X, Nogues I, Li X, Guo W, Wang Y, Fang W, Qiu M, Hou Y, Kovarnik T, Vocka M, Lu Y, Chen Y, Chen X, Liu Z, Zhou J, Xie C, Zhang R, Lu H, Hager GD, Yuille AL, Lu L, Shao C, Shi Y, Zhang Q, Liang T, Zhang L, Lu J(2023). Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Nature Medicine.
|
|
|
Video of the Week
|
|
| AI and Clinical Practice- The Learning Health System and AI |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2013, FDA approved trusted source ado-trastuzumab emtansine (T-DM1) to treat HER2-positive breast cancer.
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
